{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T09:58:25Z","timestamp":1785319105003,"version":"3.55.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"IMPORTANCE<\/jats:title>Although the use of pneumococcal conjugate vaccines (PCV) has reduced the overall burden of pneumococcal disease, recent measurements of pneumococcal pneumonia incidence are lacking.<\/jats:p><\/jats:sec>OBJECTIVE<\/jats:title>To prospectively quantify the burden of pneumococcal pneumonia and to assess the potential impact of the recently approved adult-specific 21-valent pneumococcal conjugate vaccine (V116).<\/jats:p><\/jats:sec>DESIGN, SETTINGS, AND PARTICIPANTS<\/jats:title>This cross-sectional study for prospective active surveillance included adults residing in defined catchment areas in Tennessee and Georgia hospitalized with clinical and radiographical evidence of community-acquired pneumonia (CAP) at 3 hospitals between 2018 and 2022. Data were analyzed from July 2024 to January 2025.<\/jats:p><\/jats:sec>MAIN OUTCOMES AND MEASURES<\/jats:title>Pneumococcal etiology was determined using an on-market serotype-agnostic urinary antigen test, serotype-specific urinary antigen detection assays covering 30 serotypes, and routine clinical tests. Overall and age-stratified incidence rates for pneumonia hospitalizations were estimated accounting for the probability of enrollment and hospital market share of enrolling hospitals within the catchment area.<\/jats:p><\/jats:sec>RESULTS<\/jats:title>Among 2016 patients hospitalized for CAP, the median (IQR) age was 60.1 (47.0-70.2) years; 726 patients (36.0%) were Black, 81 (4.0%) were Hispanic, and 1209 (60.0%) were White; 1863 patients (92.4%) lived in a community dwelling. A total of 279 patients (13.8%) hospitalized for CAP had evidence of pneumococcal pneumonia, and 198 (9.8%) had detection of serotypes included in V116. The overall estimated annual incidence of hospitalizations for all-cause CAP was 340 per 100\u202f000 adults. The incidence of hospitalizations for pneumococcal CAP and pneumococcal CAP due to serotypes included in V116 was 43 and 30 per 100\u202f000 adults, respectively. The burden of all-cause and pneumococcal CAP was consistently highest among adults age 65 years or older.<\/jats:p><\/jats:sec>CONCLUSIONS AND RELEVANCE<\/jats:title>This prospective surveillance study demonstrated a large burden of hospitalizations for CAP among US adults, with the highest burden of disease among adults age 65 years or older. A sizable fraction of CAP was caused by Streptococcus pneumoniae<\/jats:italic>, especially by serotypes included in V116.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.24783","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T15:00:27Z","timestamp":1754492427000},"page":"e2524783","source":"Crossref","is-referenced-by-count":4,"title":["All-Cause and Pneumococcal Community-Acquired Pneumonia Hospitalizations Among Adults in Tennessee and Georgia"],"prefix":"10.1001","volume":"8","author":[{"given":"Carlos G.","family":"Grijalva","sequence":"first","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly D.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Value & Implementation, Outcomes Research, Merck Sharp & Dohme LLC, a subsidiary of Merck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Jackson","family":"Resser","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia G.","family":"Whitney","sequence":"additional","affiliation":[{"name":"Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Baughman","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Kio","sequence":"additional","affiliation":[{"name":"Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Traenkner","sequence":"additional","affiliation":[{"name":"Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakea","family":"Johnson","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen F.","family":"Miller","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A.","family":"Rostad","sequence":"additional","affiliation":[{"name":"Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis W.","family":"Salazar","sequence":"additional","affiliation":[{"name":"Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Tanios","sequence":"additional","affiliation":[{"name":"Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica E.","family":"Smith","sequence":"additional","affiliation":[{"name":"Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney A.","family":"Cornelison","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin H.","family":"Han","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inci","family":"Yildirim","sequence":"additional","affiliation":[{"name":"Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Weiss","sequence":"additional","affiliation":[{"name":"Value & Implementation, Outcomes Research, Merck Sharp & Dohme LLC, a subsidiary of Merck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig S.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Value & Implementation, Outcomes Research, Merck Sharp & Dohme LLC, a subsidiary of Merck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Rouphael","sequence":"additional","affiliation":[{"name":"Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley H.","family":"Self","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"PNEUMO Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Shipman","sequence":"additional","affiliation":[{"name":"for the PNEUMO Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel","family":"Bristow","sequence":"additional","affiliation":[{"name":"for the PNEUMO Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zayna","family":"Al-Husein","sequence":"additional","affiliation":[{"name":"for the PNEUMO Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Anderson","sequence":"additional","affiliation":[{"name":"for the PNEUMO Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifeyinwa K","family":"Benyeogor","sequence":"additional","affiliation":[{"name":"for the PNEUMO Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Cheng","sequence":"additional","affiliation":[{"name":"for the PNEUMO Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Ha","family":"Choi","sequence":"additional","affiliation":[{"name":"for the PNEUMO Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalel","family":"De Castro","sequence":"additional","affiliation":[{"name":"for the PNEUMO Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Drobeniuc","sequence":"additional","affiliation":[{"name":"for the PNEUMO Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieffer","family":"Hellmeister","sequence":"additional","affiliation":[{"name":"for the PNEUMO Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Kay","sequence":"additional","affiliation":[{"name":"for the PNEUMO Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Lee","sequence":"additional","affiliation":[{"name":"for the PNEUMO Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikash","family":"Patel","sequence":"additional","affiliation":[{"name":"for the PNEUMO Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia D","family":"Reese","sequence":"additional","affiliation":[{"name":"for the PNEUMO Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Grace","family":"Taylor","sequence":"additional","affiliation":[{"name":"for the PNEUMO Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Taylor","sequence":"additional","affiliation":[{"name":"for the PNEUMO Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley","family":"Washington","sequence":"additional","affiliation":[{"name":"for the PNEUMO Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Zhang","sequence":"additional","affiliation":[{"name":"for the PNEUMO Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelyn","family":"Ruggieri","sequence":"additional","affiliation":[{"name":"for the PNEUMO Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"issue":"9","key":"zoi250704r1","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S1473-3099(24)00176-2","article-title":"Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.","volume":"24","author":"GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"zoi250704r2","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00015-22","article-title":"The microbial etiology of community-acquired pneumonia in adults: from classical bacteriology to host transcriptional signatures.","volume":"35","author":"Gadsby","year":"2022","journal-title":"Clin Microbiol Rev"},{"key":"zoi250704r3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s41479-020-00074-3","article-title":"Etiology of community-acquired pneumonia in adults: a systematic review.","volume":"12","author":"Shoar","year":"2020","journal-title":"Pneumonia (Nathan)"},{"issue":"7","key":"zoi250704r4","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America.","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"zoi250704r5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among US adults.","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi250704r6","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/cid\/ciae316","article-title":"Prevalence, clinical severity, and serotype distribution of pneumococcal pneumonia among adults hospitalized with community-acquired pneumonia in Tennessee and Georgia, 2018-2022.","volume":"79","author":"Self","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"7","key":"zoi250704r7","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/cid\/ciab375","article-title":"Expanded analysis of 20 pneumococcal serotypes associated with radiographically confirmed community-acquired pneumonia in hospitalized US adults.","volume":"73","author":"Isturiz","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"zoi250704r8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7203a1","article-title":"Pneumococcal vaccine for adults aged =19 years: recommendations of the Advisory Committee on Immunization Practices, United States, 2023.","volume":"72","author":"Kobayashi","year":"2023","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"zoi250704r9","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/cid\/ciae383","article-title":"A phase 3 clinical study to evaluate the safety, tolerability, and immunogenicity of V116 in pneumococcal vaccine-experienced adults 50 years of age or older (STRIDE-6).","volume":"79","author":"Scott","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"10","key":"zoi250704r10","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S1473-3099(24)00344-X","article-title":"Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial.","volume":"24","author":"Platt","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"zoi250704r11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.mm7401a1","article-title":"Expanded recommendations for use of pneumococcal conjugate vaccines among adults aged =50 years: recommendations of the Advisory Committee on Immunization Practices\u2013United States, 2024.","volume":"74","author":"Kobayashi","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"36","key":"zoi250704r12","doi-asserted-by":"publisher","first-page":"793","DOI":"10.15585\/mmwr.mm7336a3","article-title":"Use of 21-valent pneumococcal conjugate vaccine among U.S. adults: recommendations of the Advisory Committee on Immunization Practices\u2013United States, 2024.","volume":"73","author":"Kobayashi","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"25","key":"zoi250704r13","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1016\/j.vaccine.2019.04.087","article-title":"Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia.","volume":"37","author":"Isturiz","year":"2019","journal-title":"Vaccine"},{"issue":"10","key":"zoi250704r14","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/cid\/cix1066","article-title":"Pneumococcal community-acquired pneumonia detected by serotype-specific urinary antigen detection assays.","volume":"66","author":"Wunderink","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"13","key":"zoi250704r15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1080\/17576180.2024.2357030","article-title":"Qualification of a 21-valent pneumococcal urine antigen detection assay and development of clinical positivity cutoffs.","volume":"16","author":"Choudhury","year":"2024","journal-title":"Bioanalysis"},{"issue":"4","key":"zoi250704r16","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00114-22","article-title":"Development and validation of a sensitive and robust multiplex antigen capture assay to quantify streptococcus pneumoniae serotype-specific capsular polysaccharides in urine.","volume":"7","author":"Rajam","year":"2022","journal-title":"mSphere"},{"issue":"11","key":"zoi250704r18","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1093\/cid\/cix647","article-title":"Adults hospitalized with pneumonia in the United States: Incidence, Epidemiology, and Mortality.","volume":"65","author":"Ramirez","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"5","key":"zoi250704r19","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1093\/cid\/ciaa1728","article-title":"Impact of the coronavirus disease 2019 (COVID-19) pandemic on invasive pneumococcal disease and risk of pneumococcal coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): prospective national cohort study, England.","volume":"72","author":"Amin-Chowdhury","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"6","key":"zoi250704r20","doi-asserted-by":"publisher","first-page":"e360","DOI":"10.1016\/S2589-7500(21)00077-7","article-title":"Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data.","volume":"3","author":"Brueggemann","year":"2021","journal-title":"Lancet Digit Health"},{"issue":"10","key":"zoi250704r21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-055575","article-title":"Invasive pneumococcal disease, pneumococcal pneumonia and all-cause pneumonia in Hong Kong during the COVID-19 pandemic compared with the preceding 5 years: a retrospective observational study.","volume":"11","author":"Chan","year":"2021","journal-title":"BMJ Open"},{"issue":"4","key":"zoi250704r22","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.vaccine.2019.10.101","article-title":"Rates of hospitalization for community-acquired pneumonia among US adults: a systematic review.","volume":"38","author":"McLaughlin","year":"2020","journal-title":"Vaccine"},{"issue":"4","key":"zoi250704r23","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv135","article-title":"In-hospital pneumococcal polysaccharide vaccination is associated with detection of pneumococcal vaccine serotypes in adults hospitalized for community-acquired pneumonia.","volume":"2","author":"Grijalva","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"zoi250704r24","doi-asserted-by":"publisher","first-page":"e430","DOI":"10.1093\/cid\/ciaa158","article-title":"Qualification and clinical validation of an immunodiagnostic assay for detecting 11 additional Streptococcus pneumoniae serotype-specific polysaccharides in human urine.","volume":"71","author":"Kalina","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"zoi250704r25","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1183\/09031936.00137412","article-title":"Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia.","volume":"42","author":"Huijts","year":"2013","journal-title":"Eur Respir J"},{"issue":"11","key":"zoi250704r26","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/infdis\/jit506","article-title":"Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged =50 years with community-acquired pneumonia.","volume":"208","author":"Sherwin","year":"2013","journal-title":"J Infect Dis"},{"issue":"8","key":"zoi250704r27","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1128\/CVI.00064-12","article-title":"Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urine.","volume":"19","author":"Pride","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"zoi250704r28","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1186\/s12879-022-07732-5","article-title":"The changing spectrum of microbial aetiology of respiratory tract infections in hospitalized patients before and during the COVID-19 pandemic.","volume":"22","author":"Serigstad","year":"2022","journal-title":"BMC Infect Dis"},{"key":"zoi250704r17","unstructured":"US Census Bureau. County population by characteristics. Revised June 27, 2024. Accessed November 15, 2024. https:\/\/www.census.gov\/data\/tables\/time-series\/demo\/popest\/2020s-counties-detail.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2837323\/grijalva_2025_oi_250704_1753891365.17515.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T15:00:28Z","timestamp":1754492428000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2837323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.24783","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]}}}